ULISSE BIOMEDULISSE BIOMEDULISSE BIOMED

ULISSE BIOMED

No trades
See on Supercharts
Market capitalization
‪18.02 M‬EUR
−0.214EUR
‪−2.47 M‬EUR
‪66.21 K‬EUR
Beta (1Y)
0.94

About ULISSE BIOMED


CEO
Nicola Basile
Headquarters
Udine
Founded
2015
ISIN
IT0005451213
FIGI
BBG011WZR478
Ulisse BioMed SpA is an Italian healthcare biotech company. It engages in creating novel, innovative and transformative diagnostic platforms and products. The company was founded in 2015 and is headquartered in Udine, Italy.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of UBM is 0.818 EUR — it has increased by 6.79% in the past 24 hours. Watch ULISSE BIOMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ULISSE BIOMED stocks are traded under the ticker UBM.
UBM stock has risen by 4.87% compared to the previous week, the month change is a −5.98% fall, over the last year ULISSE BIOMED has showed a −51.88% decrease.
UBM reached its all-time high on Aug 12, 2021 with the price of 7.550 EUR, and its all-time low was 0.754 EUR and was reached on Dec 19, 2024. View more price dynamics on UBM chart.
See other stocks reaching their highest and lowest prices.
UBM stock is 8.20% volatile and has beta coefficient of 0.94. Track ULISSE BIOMED stock price on the chart and check out the list of the most volatile stocks — is ULISSE BIOMED there?
Today ULISSE BIOMED has the market capitalization of ‪18.02 M‬, it has increased by 3.37% over the last week.
Yes, you can track ULISSE BIOMED financials in yearly and quarterly reports right on TradingView.
UBM net income for the last half-year is ‪−3.07 M‬ EUR, while the previous report showed ‪−1.57 M‬ EUR of net income which accounts for −95.11% change. Track more ULISSE BIOMED financial stats to get the full picture.
No, UBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ULISSE BIOMED EBITDA is ‪−3.47 M‬ EUR, and current EBITDA margin is ‪−3.53 K‬%. See more stats in ULISSE BIOMED financial statements.
Like other stocks, UBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ULISSE BIOMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ULISSE BIOMED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ULISSE BIOMED stock shows the sell signal. See more of ULISSE BIOMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.